FDA Inspection 1315964 — HonorBridge

HonorBridge — FEI 3003651458

The FDA completed an inspection of HonorBridge on April 23, 2026 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 23, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Durham, NC (United States)